PREOPERATIVE AND POSTOPERATIVE EVALUATION OF PROSTATE-SPECIFIC ANTIGEN IN LOCALIZED PROSTATIC-CANCER TREATED BY RADICAL PROSTATECTOMY

被引:0
|
作者
ZATTONI, F
PIAZZA, R
VIANELLO, R
GARBEGLIO, A
PAGANO, F
机构
关键词
PROSTATIC CARCINOMA; PROSTATE-SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Preoperative prostate-specific antigen (PSA) values were determined in 73 patients with clinically localized prostatic cancer and candidates for a radical procedure. Correlation of preoperative PSA with a final pathological stage was attempted. Only i n 44.8% of our 22 patients with organ-confined disease was the PSA value within the normal range; in 17.3% of cases PSA values were higher than 20 ng/ml. 18.2% of the patients with locally advanced disease showed normal PSA values, while 45.5% had concentrations above 20 ng/ml. In the case of lymph node involvement, PSA values were normal in 22.7% of the cases. Our data indicate that no strict relationship can be suggested between PSA and the final pathological stage and grading of the tumor in patients who underwent radical prostatectomy.
引用
收藏
页码:99 / 101
页数:3
相关论文
共 50 条
  • [31] TOTAL PROSTATECTOMY FOR LOCALIZED PROSTATIC-CANCER
    GIBBONS, RP
    CORREA, RJ
    BRANNEN, GE
    MASON, JT
    JOURNAL OF UROLOGY, 1984, 131 (01): : 73 - 76
  • [32] PROSTATE-SPECIFIC ANTIGEN TEST - OPERATING CHARACTERISTICS AND ASSESSMENT CRITERIA IN THE DIAGNOSIS OF PROSTATIC-CANCER
    PERIMENIS, P
    MARKOU, SA
    BARBALIAS, G
    UROLOGIA INTERNATIONALIS, 1992, 48 (02) : 171 - 174
  • [33] DIAGNOSTIC-VALUE OF PROSTATIC ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATIC-CANCER
    PAGANI, F
    ZAMBOLIN, T
    BONORA, R
    PANTEGHINI, M
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1990, 34 (04): : 85 - 87
  • [34] POSTOPERATIVE PROSTATE-SPECIFIC ANTIGEN LEVELS IN PATHOLOGICAL STAGE-C ADENOCARCINOMA OF THE PROSTATE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY ALONE
    ROBINOW, JS
    SCHILD, SE
    TOMERA, KM
    WOLFE, JT
    BUSKIRK, SJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 228 - 229
  • [35] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 553 - 554
  • [36] USE OF HUMAN PROSTATE-SPECIFIC ANTIGEN IN THE DIAGNOSIS OF PROSTATIC-CANCER - PRELIMINARY-REPORT
    CAMMAROTA, HE
    PRENSA MEDICA ARGENTINA, 1988, 75 (12): : 498 - 499
  • [37] Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
    Tilki, Derya
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Trock, Bruce J.
    Han, Misop
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2025,
  • [38] Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate
    Cross, CK
    Shultz, D
    Malkowicz, SB
    Huang, WC
    Whittington, R
    Tomaszewski, JE
    Renshaw, AA
    Richie, JP
    D'Amico, AV
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2863 - 2868
  • [39] PROSTATE SPECIFIC ANTIGEN AS A SERUM MARKER FOR PROSTATIC-CANCER
    NEELS, H
    SMEUNINX, M
    FRANCK, F
    VANERPS, P
    DENIS, L
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 314 - 314
  • [40] Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy
    Thomas, J
    Gupta, M
    Grasso, Y
    Reddy, CA
    Heston, WD
    Zippe, C
    Dreicer, R
    Kupelian, PA
    Brainard, J
    Levin, HS
    Klein, EA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3213 - 3218